Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
0.9400
-0.0322 (-3.31%)
At close: Oct 23, 2026, 4:00 PM EDT
0.9524
+0.0124 (1.32%)
After-hours: Oct 23, 2026, 7:55 PM EDT
Tvardi Therapeutics Market Cap
Tvardi Therapeutics has a market cap or net worth of $12.54 million as of October 23, 2026. It is the 40,069th most valuable company in the world and the 5,468th biggest in the United States. Its market cap has decreased by 74.43% in one year.
Market Cap
12.54M
Enterprise Value
-3.08M
1-Year Change
-74.43%
Global Rank
Country Rank
#5,468 United States
Category
ChartMarket Cap Chart
Since April 16, 2025, Tvardi Therapeutics's market cap has decreased from $170.73M to $12.54M, a decrease of -92.66%. That is a compound annual growth rate of -82.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 12.54M | -68.92% |
| Dec 31, 2025 | 40.34M | -76.37% |
| Apr 16, 2025 | 170.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioCardia | 14.06M |
| Allarity Therapeutics | 13.47M |
| Cerenome | 13.28M |
| Daré Bioscience | 12.82M |
| Vyome Holdings | 12.63M |
| Pluri | 12.47M |
| Actuate Therapeutics | 12.40M |
| Karyopharm Therapeutics | 12.39M |